trending Market Intelligence /marketintelligence/en/news-insights/trending/cjxusmyv5yeou5-jnb5-2w2 content esgSubNav
In This List

Bionomics CEO appointed Bioasis chair

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Bionomics CEO appointed Bioasis chair

Canadian biopharmaceutical company Bioasis Technologies Inc. appointed Deborah Rathjen to be the chair of its board.

Rathjen takes over from former board chair and CEO Rob Hutchison, who retired Dec. 4, 2017.

Rathjen is the CEO and managing director of Bionomics Ltd.